Extranodal NK-T-cell lymphoma primary prevention

	Extranodal NK-T-cell lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Extranodal NK-T-cell lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Xray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Extranodal NK-T-cell lymphoma primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Extranodal NK-T-cell lymphoma primary prevention
CDC on Extranodal NK-T-cell lymphoma primary prevention
Extranodal NK-T-cell lymphoma primary prevention in the news
Blogs on Extranodal NK-T-cell lymphoma primary prevention
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD [2]

Overview

There are no established measures for the primary prevention of extranodal NK/T cell lymphoma.

There are no established measures for the primary prevention of extranodal NK/T cell lumphoma.^[1]

↑ Liang, Raymond (2009). "Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type". British Journal of Haematology. 147 (1): 13–21. doi:10.1111/j.1365-2141.2009.07802.x. ISSN 0007-1048.